Vlaeminck-Guillem, V. (2020). Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer. Transl Androl Urol.
Style de citation ChicagoVlaeminck-Guillem, Virginie. "Clinical Utility of the Nuclear-localized AR-V7 Biomarker for Treatment Choice in Metastatic Castration-resistant Prostate Cancer." Transl Androl Urol 2020.
Style de citation MLAVlaeminck-Guillem, Virginie. "Clinical Utility of the Nuclear-localized AR-V7 Biomarker for Treatment Choice in Metastatic Castration-resistant Prostate Cancer." Transl Androl Urol 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.